A new mutation in latent TGF-β-binding protein 4 (LTBP4) gene was found in 10% of recurrent GBM, whilst the TGF-β pathway was also found to be involved in tumor pathogenesis (56). This evidence concerns the gene TGFB1 and glioblastoma.